Meeting & Deadlines
2020 Deadlines
| Month | Deadline to Submit HGT Protocol* | Deadline to Submit Non- HGT Protocol | Meeting Date | Notify PI By |
|---|---|---|---|---|
| November | October 8, 2020 | October 28, 2020 | November 12, 2020 | November 19, 2020 |
| December | November 12, 2020 | November 25, 2020 | December 10, 2020 | December 17, 2020 |
2021 Deadlines
| Month | Deadline to Submit HGT Protocol* | Deadline to Submit Non- HGT Protocol | Meeting Date | Notify PI By |
|---|---|---|---|---|
| January | December 10, 2020** | December 10, 2020** | January 14, 2021 | January 22, 2021 |
| February | January 6, 2021 | January 27, 2021 | February 11, 2021 | February 19, 2021 |
| March | February 11, 2021 | February 24, 2021 | March 11, 2021 | March 19, 2021 |
| April | March 11, 2021 | March 24, 2021 | April 8, 2021 | April 16, 2021 |
| May | April 8, 2021 | April 28, 2021 | May 13, 2021 | May 21, 2021 |
| June | May 13, 2021 | May 26, 2021 | June 10, 2021 | June 18, 2021 |
| July | June 10, 2021 | June 23, 2021 | July 8, 2021 | July 16, 2021 |
| August | July 8, 2021 | July 28, 2021 | August 12, 2021 | August 20, 2021 |
| September | August 13, 2021 | August 25, 2021 | September 09, 2021 | September 17, 2021 |
| October | September 9, 2021 | September 22, 2021 | October 14, 2021 | October 22, 2021 |
| November | October 7, 2021 | October 27, 2021 | November 11, 2021 | November 19, 2021 |
| December | November 11, 2021 | November 24, 2021 | December 9, 2021 | December 17, 2021 |
deadline
* Any investigator planning to submit a study involving Human Gene Transfer (HGT) or Infectious Agents must contact IBC office prior to submission of the study to discuss study scope and required documentation. HGT and Infectious Agents used in humans are defined as follows:
- deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into one or more human subjects (in vivo transfer);
- deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into cells that will be transferred into one or more human subjects (ex vivo transfer);
- deliberate transfer of synthetic nucleic acid molecules, or DNA or RNA derived from synthetic nucleic acid molecules, that meet any one of the following criteria:
- Contain more than 100 nucleotides; or
- Possess biological properties that enable integration into the genome (e.g., cis elements involved in integration); or
- Have the potential to replicate in a cell; or
- Can be translated or transcribed
- infectious agents- any agent that is nonrecombinant in nature that is BSL 2 such as some vaccines or toxins.
** Please note that this deadline is earlier than other months due to holiday schedule.
Should you have any questions, please contact the IBC office at oacib@uic.edu